Literature DB >> 24985015

Late-onset urea cycle disorder in adulthood unmasked by severe malnutrition.

Diana L Wells1, Jillian B Thomas2, Gordon S Sacks3, L Anna Zouhary4.   

Abstract

Urea cycle disorders (UCDs) most often involve inherited deficiencies in genes that code for enzymes normally used by the urea cycle to breakdown nitrogen. UCDs lead to serious metabolic complications, including severe neurologic decompensation related to hyperammonemia. Although the majority of UCDs are revealed soon after birth, stressful events in adulthood can lead to unmasking of a partial, late-onset UCDs. In this report, we describe a late-onset UCD unmasked by severe malnutrition. Early, specialized nutrition therapy is a fundamental aspect of treating hyperammonemic crises in patients with UCD. The case presented here demonstrates the importance of early recognition of UCD and appropriate interventions with nutrition support.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Hyperammonemia; Malnutrition; Urea cycle disorder

Mesh:

Substances:

Year:  2013        PMID: 24985015     DOI: 10.1016/j.nut.2013.12.011

Source DB:  PubMed          Journal:  Nutrition        ISSN: 0899-9007            Impact factor:   4.008


  3 in total

Review 1.  Fifteen years of urea cycle disorders brain research: Looking back, looking forward.

Authors:  Kuntal Sen; Matthew Whitehead; Carlos Castillo Pinto; Ljubica Caldovic; Andrea Gropman
Journal:  Anal Biochem       Date:  2021-10-09       Impact factor: 3.365

Review 2.  Review of Multi-Modal Imaging in Urea Cycle Disorders: The Old, the New, the Borrowed, and the Blue.

Authors:  Kuntal Sen; Afrouz A Anderson; Matthew T Whitehead; Andrea L Gropman
Journal:  Front Neurol       Date:  2021-04-28       Impact factor: 4.086

Review 3.  Management of late onset urea cycle disorders-a remaining challenge for the intensivist?

Authors:  S Redant; A Empain; A Mugisha; P Kamgang; R Attou; P M Honoré; D De Bels
Journal:  Ann Intensive Care       Date:  2021-01-06       Impact factor: 6.925

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.